Back to UBS Group AG UBS Group AG

STIMSTIM
Showing 8 of 29 quarters

Position history for UBS Group AGUBS Group AG's holdings in NEURONETICS INC

UBS Group AG holds 2.3M shares of STIM (NEURONETICS INC), worth $3M as of 2026-Q2. The position was decreased (-20.6% shares). STIM represents 0.0% of UBS Group AG's portfolio.

Current Value

$3M

Current Shares

2.3M

Total Value Change

+$3M

Total Shares Change

+2.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2.3M
-20.6%
$3M0.0%$1.30
0
2026-Q1
Increased
2.9M
+10.1%
$4.2M0.0%$1.27
29
2025-Q4
Increased
2.6M
+20.4%
$3.6M0.0%$1.41
32
2025-Q3
Increased
2.2M
+580.7%
$5.9M0.0%$2.66
44
2025-Q2
Increased
318,030
+183.7%
$1.1M0.0%$3.53
41
2025-Q1
Decreased
112,114
-72.2%
$412,5800.0%$3.77
0
2024-Q4
Increased
403,624
+6100.1%
$649,8350.0%$1.48
39
2024-Q3
Decreased
6,510
-90.2%
$4,9470.0%$0.75
0

Other major holders of STIM: BNP PARIBAS FINANCIAL MARKETS, Capital Research Global Investors, Polar Capital Holdings Plc, FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used